Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution. (August 2021)
- Record Type:
- Journal Article
- Title:
- Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution. (August 2021)
- Main Title:
- Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution
- Authors:
- Di Stasio, G.D.
Travascio, L.
Colandrea, M.
Spaggiari, L.
Sorbello, S.
Ferrari, M.E.
Maisonneuve, P.
Galetta, D.
Travaini, L.
Grana, C.M. - Abstract:
- Highlights: Pleomorphic lung carcinoma (PLC) is a rare histotype of lung cancer. PLC is characterized by aggressive clinical course and poor prognosis. 18F-FDG PET/CT can be helpful in stratification of patients. Metabolic parameters such as SUVmax, MTV and TLG provide additional information. Abstract: Objectives: Pleomorphic lung carcinoma (PLC) is a rare histotype of non-small cell lung cancer (NSCLC) characterized by aggressive clinical course, poor response to therapy and poor prognosis. Therefore, aim of our study is to analyze with 18F-FDG PET/CT a subset of patients affected by PLC to evaluate their metabolic characteristics in terms of SUVmax, MTV and TLG, in order to correlate them with overall survival (OS) and disease-free survival (DFS). Material and methods: We retrospectively analyzed 49 consecutive patients with histologically defined PLC occurred to our Institution between 2003 and 2014. All patients underwent F18-FDG PET-CT before surgery and primary tumor was automatically segmented using an isocontour threshold method. SUV threshold for tumor segmentation was defined as the 41 % of lesion SUVmax. Total volume of the segmented VOI (MTV, centimeters cubed) and average SUV (SUVavg, grams per milliliter) in the segmented VOI were measured. Results: In our population men were significantly more affected than women (42:7). According to Youden criteria, SUVmax, MTV41 and TLG41 best cut-off values to predict 2-year mortality were, 18.95, 27.89 and 290.45,Highlights: Pleomorphic lung carcinoma (PLC) is a rare histotype of lung cancer. PLC is characterized by aggressive clinical course and poor prognosis. 18F-FDG PET/CT can be helpful in stratification of patients. Metabolic parameters such as SUVmax, MTV and TLG provide additional information. Abstract: Objectives: Pleomorphic lung carcinoma (PLC) is a rare histotype of non-small cell lung cancer (NSCLC) characterized by aggressive clinical course, poor response to therapy and poor prognosis. Therefore, aim of our study is to analyze with 18F-FDG PET/CT a subset of patients affected by PLC to evaluate their metabolic characteristics in terms of SUVmax, MTV and TLG, in order to correlate them with overall survival (OS) and disease-free survival (DFS). Material and methods: We retrospectively analyzed 49 consecutive patients with histologically defined PLC occurred to our Institution between 2003 and 2014. All patients underwent F18-FDG PET-CT before surgery and primary tumor was automatically segmented using an isocontour threshold method. SUV threshold for tumor segmentation was defined as the 41 % of lesion SUVmax. Total volume of the segmented VOI (MTV, centimeters cubed) and average SUV (SUVavg, grams per milliliter) in the segmented VOI were measured. Results: In our population men were significantly more affected than women (42:7). According to Youden criteria, SUVmax, MTV41 and TLG41 best cut-off values to predict 2-year mortality were, 18.95, 27.89 and 290.45, respectively, with TLG41 showing best specificity (85 %) and positive predictive value (82.4 %). As concerning 2-year recurrence, SUVmax, MTV41 and TLG41 best cut-off values were 10.08, 27.89 and 134.85, with SUVmax showing best sensitivity (96.7 %) and negative predictive value (85.7 %). ROC curves confirmed that SUVmax, MTV41 and TLG41 were equally accurate to predict 2-year mortality and 2-year recurrence in our population. Conclusion: Metabolic biomarkers such as SUVmax, MTV and TLG can be used as a prognostic index for disease progression, recurrence and death in patients with PLC, independently from other clinical/pathological prognostic elements. … (more)
- Is Part Of:
- Lung cancer. Volume 158(2021)
- Journal:
- Lung cancer
- Issue:
- Volume 158(2021)
- Issue Display:
- Volume 158, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 158
- Issue:
- 2021
- Issue Sort Value:
- 2021-0158-2021-0000
- Page Start:
- 40
- Page End:
- 46
- Publication Date:
- 2021-08
- Subjects:
- Pleomorphic lung cancer -- FDG PET/CT -- Metabolic parameters -- Prognostic value -- Positron emission tomography
Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.lungcan.2021.05.027 ↗
- Languages:
- English
- ISSNs:
- 0169-5002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17544.xml